Golden Sunshine USA, Inc. – Trademark Portfolio
Entity Type: 03
Golden Sunshine USA, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GOLDEN SUNSHINE, PAIN TERMINATOR, and TIMELESS BEAUTY, AGELESS SKIN. The owner is based in Brea, CA.
2880 E. Imperial Hwy.
Brea, CA 928216714
Showing of trademarks Trademarks
Trademark Classifications
Golden Sunshine USA, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Golden Sunshine USA, Inc. have?
Golden Sunshine USA, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 4 cancelled.
What trademark classes does Golden Sunshine USA, Inc. file in?
Golden Sunshine USA, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Golden Sunshine USA, Inc.'s most well-known trademarks?
Golden Sunshine USA, Inc.'s registered trademark portfolio includes well-known marks such as GOLDEN SUNSHINE, PAIN TERMINATOR, and TIMELESS BEAUTY, AGELESS SKIN. These are among 3 currently registered trademarks in the portfolio.
What is Golden Sunshine USA, Inc.'s trademark registration success rate?
Golden Sunshine USA, Inc. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.